Sheharyar Raza: Examining Guideline Discordance in Evidence-Based Apheresis Recommendations
Sheharyar Raza, Transfusion Medicine Specialist and Data Scientist at University Health Network, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“In evidence based medicine, ‘discordance’ is when recommendations don’t align with evidence, either in strength or direction
Co-authors Jeremy Jacobs, et al examined discordance in the American Society for Apheresis guidelines, widely used to justify which patients should get exchange transfusions. The thrust of our argument is that although some discordance is expected in clinical areas dealing with clinical areas where it is harder to perform large studies (e.g. rare diseases), each instance should be transparently acknowledged and justified to highlight knowledge gaps and uncertainty.”
Title: When Strong Recommendations Rest on Weak Evidence: Lessons From Therapeutic Apheresis Guidelines
Authors: Jeremy W. Jacobs, Garrett S. Booth, Brian D. Adkins, Victoria Costa, Sheharyar Raza, Yara A. Park, Joseph Yossi Schwartz, Evan M. Bloch
Read the Full Article on Journal of Clinical Apheresis

More posts featuring Sheharyar Raza on Hemostasis Today.
-
Jul 12, 2026, 08:50Where the Hemophilia Community Comes Together at ISTH 2026 – EAHAD
-
Jul 12, 2026, 08:2210 Posts Not To Miss from ISTH 2026, Part 1
-
Jul 12, 2026, 07:58Brian O Mahony: Could NXT-007 Minimize the Need for Perioperative FVIII
-
Jul 12, 2026, 07:50Shayan Mohammadmoradi: Connecting the Next Generation of Hemostasis Researchers at ISTH 2026
-
Jul 12, 2026, 07:42Alexandra Yakusheva: ThrombInnov Debuts at ISTH 2026 with a Focus on Translational Research
-
Jul 12, 2026, 07:34Wolfgang Miesbach: ISTH 2026 Explores the Next Generation of APS Diagnostics
-
Jul 12, 2026, 07:28Sara Zalghout: ISTH 2026 Highlights Progress in Thromboinflammation Research
-
Jul 12, 2026, 07:13Ekaterina Balaian: Finding Healing Through Art at ISTH 2026
-
Jul 12, 2026, 06:59Maaike Sybil Jongen: Flow Cytometry for Platelet Phenotyping at ISTH 2026